Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
NCT01148407 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2011-04-22
Summary
Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.
Conditions
Sponsors & Collaborators
-
University of Vermont
lead OTHER
Principal Investigators
-
Chris E Holmes, MD PhD · University of Vermont
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2012-08-31
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913 ·Status: COMPLETED
-
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
NCT00096590 ·Status: COMPLETED
-
Pathogenesis of Hematologic Malignancies
NCT01728402 ·Status: ENROLLING_BY_INVITATION
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Integrated Molecular Profiling in Advanced Cancers Trial
NCT01505400 ·Status: ACTIVE_NOT_RECRUITING
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
NCT06304168 ·Status: RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
NCT03727087 ·Status: TERMINATED
-
Tissue Microarray of Hematological Malignancies
NCT04142372 ·Status: ACTIVE_NOT_RECRUITING
-
Identifying Molecular Drivers of Cancer
NCT02470715 ·Status: COMPLETED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
IP3R Modulation by Cancer Genes in Mesothelioma
NCT03558932 ·Status: UNKNOWN
-
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01057095 ·Status: COMPLETED
-
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
NCT07149207 ·Status: RECRUITING ·Phase: PHASE2
-
Identification of Key Blood Molecular Markers for Immunotherapy
NCT00507702 ·Status: TERMINATED
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
NCT01010256 ·Status: TERMINATED
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
NCT03727009 ·Status: TERMINATED
-
Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT)
NCT06367751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular Markers in Cancers and Precancers (MOCA)
NCT05257707 ·Status: WITHDRAWN ·Phase: NA
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED